Enhabit, Inc. (NYSE:EHAB) Receives $9.35 Average PT from Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have received an average rating of “Reduce” from the seven analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating and six have issued a hold rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $9.25.

Separately, Leerink Partners reissued a “market perform” rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. SummerHaven Investment Management LLC boosted its holdings in shares of Enhabit by 2.8% in the 2nd quarter. SummerHaven Investment Management LLC now owns 61,508 shares of the company’s stock valued at $549,000 after buying an additional 1,660 shares during the period. FMR LLC boosted its holdings in shares of Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after buying an additional 1,967 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Enhabit by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company’s stock valued at $443,000 after buying an additional 2,078 shares during the period. Quarry LP boosted its holdings in shares of Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after buying an additional 2,621 shares during the period. Finally, Gladius Capital Management LP boosted its holdings in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after buying an additional 2,747 shares during the period.

Enhabit Stock Up 0.9 %

Shares of NYSE EHAB opened at $7.63 on Tuesday. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The firm’s 50 day moving average price is $7.50 and its 200 day moving average price is $8.38. The firm has a market cap of $383.39 million, a P/E ratio of -3.33 and a beta of 1.84. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the business earned $0.03 EPS. As a group, sell-side analysts anticipate that Enhabit will post 0.22 earnings per share for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.